Benzinga | Nov 3, 2021 09:15AM EDT

SVB Leerink Maintains Market Perform on Amgen, Lowers Price Target to $216

SVB Leerink analyst Geoffrey Porges maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $234 to $216.